Pfizer

We may think we have a handle on the Omicron variant, but are we sure? People are certainly being hospitalised, and some are dying, albeit thankfully in low numbers. Professor Gary McLean joins the… Audio

Professor Michael Baker is back with us to discuss the Omicron variant, the increased risks Covid survivors face, and the idea that the time of day a person receives their vaccine has an impact on the… Audio

New Zealander Dr Gary McLean is back with us on Sunday Morning to look at the latest Covid-19 developments. Professor McLean will discuss the spread of the dangerous new Omicron variant (and its 33… Audio

Dr Doug Wilson is a medical academic author and our regular correspondent from the other side of 80. This week he returns to discuss Pfizer's new oral antiviral drug for use against Covid-19. Audio

There's been a mixed reaction from residents in Thames after the district's mayor said she won't take the Pfizer Covid-19 vaccine.

Sandra Goudie says she's waiting instead for the Novavax vaccine… Audio

Kathryn talks with Massey University migration expert Paul Spoonley about how international mobility will be managed once New Zealand's borders reopen in the New Year. He says there are some big, as… Audio

As of Friday afternoon, more than 70 percent of New Zealanders aged 12 or over had received their first dose of the Pfizer vaccine, or are booked in to receive it. But as witnessed in Israel, where… Audio

Wellingtonian Sean Barry lives in Yasamal, which is a 10 minutes' walk from the centre of Baku, the capital of Azerbaijan. A teacher by trade, Sean lives in an apartment with his wife Jamila and… Audio, Gallery

A prominent New Zealand scientist is calling for security of vaccine supply through self sufficiency, saying it's not only viable, but vital. Director of the Vaccine Alliance Aotearoa NZ Professor… Audio

Joining us again on Sunday morning is New Zealander Dr Gary McLean. He discusses the Delta variant, what type of masks we should be wearing, and why annual Covid-19 booster shots are going to be… Audio

New Zealand’s ‘COVID-naive’ population will offer unique data to global research as part of a new clinical study looking at how our bodies respond to the Pfizer-BioNTech vaccine. Audio

Against a backdrop of news reports about shortages and anger over delayed Covid-19 vaccinations, a Herald opinion piece this week claimed our supply would run dry within days. But swift fact-checking… Audio

New Zealand will receive a further one million doses of the Pfizer Covid-19 vaccination next month.

The new shipments will arrive in weekly drops - ramping up from mid-July ahead of the roll out to… Video, Audio

Science commentator Siouxsie Wiles joins Kathryn to talk about the latest Covid studies, including the 80 per cent rollout of the Pfizer vaccine to Israeli adults and the safety of the vaccine for… Audio

New Zealander Gary McLean is an international authority on coronaviruses. Professor McLean is with us to look at Long Covid, the vaccine rollouts, and the fact that Covid sticks around the body longer… Audio

The Director-General of Health has revealed students 12 years and older could get their Covid-19 jabs in a school-based vaccination prorgramme starting at the end of Term 3.

And in a pre-Budget… Video, Audio

New Zealand Professor Gary McLean is with us to look at all of the latest news relating to the Covid-19 pandemic, including what the longevity of immunity is likely to be and how Covid-19 has become a… Audio

It has been confirmed the latest managed isolation and quarantine worker to test positive for Covid-19 had recently received the required second dose of the Pfizer vaccine.

The vaccine is proving to… Video, Audio